
Nancy J. Leith
Examiner (ID: 12198, Phone: (313)446-4874 , Office: P/1636 )
| Most Active Art Unit | 1636 |
| Art Unit(s) | 1636, 1811, 1815, 1941, 1805 |
| Total Applications | 1445 |
| Issued Applications | 999 |
| Pending Applications | 194 |
| Abandoned Applications | 284 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10671228
[patent_doc_number] => 20160017372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-21
[patent_title] => 'METHODS AND PRODUCTS FOR PRODUCING ENGINEERED MAMMALIAN CELL LINES WITH AMPLIFIED TRANSGENES'
[patent_app_type] => utility
[patent_app_number] => 14/806175
[patent_app_country] => US
[patent_app_date] => 2015-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 35122
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14806175
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/806175 | Methods and products for producing engineered mammalian cell lines with amplified transgenes | Jul 21, 2015 | Issued |
Array
(
[id] => 11397284
[patent_doc_number] => 20170017820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-19
[patent_title] => 'Automatic Processing Selection Based on Tagged Genomic Sequences'
[patent_app_type] => utility
[patent_app_number] => 14/798956
[patent_app_country] => US
[patent_app_date] => 2015-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8726
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14798956
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/798956 | Automatic Processing Selection Based on Tagged Genomic Sequences | Jul 13, 2015 | Abandoned |
Array
(
[id] => 10491607
[patent_doc_number] => 20150376628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-31
[patent_title] => 'NUCLEASE-MEDIATED DNA ASSEMBLY'
[patent_app_type] => utility
[patent_app_number] => 14/747461
[patent_app_country] => US
[patent_app_date] => 2015-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 29136
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14747461
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/747461 | Nuclease-mediated DNA assembly | Jun 22, 2015 | Issued |
Array
(
[id] => 11350526
[patent_doc_number] => 20160369266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-22
[patent_title] => 'METHODS FOR ON-ARRAY FRAGMENTATION AND BARCODING OF DNA SAMPLES'
[patent_app_type] => utility
[patent_app_number] => 14/745174
[patent_app_country] => US
[patent_app_date] => 2015-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 10850
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14745174
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/745174 | Methods for on-array fragmentation and barcoding of DNA samples | Jun 18, 2015 | Issued |
Array
(
[id] => 15513289
[patent_doc_number] => 10563222
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-18
[patent_title] => Promoters for high level expression
[patent_app_type] => utility
[patent_app_number] => 15/319730
[patent_app_country] => US
[patent_app_date] => 2015-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 8449
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 229
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15319730
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/319730 | Promoters for high level expression | Jun 16, 2015 | Issued |
Array
(
[id] => 10656467
[patent_doc_number] => 20160002611
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-07
[patent_title] => 'Methods and Apparatus for Cell-Free Microfluidic-Assisted Biosynthesis'
[patent_app_type] => utility
[patent_app_number] => 14/735132
[patent_app_country] => US
[patent_app_date] => 2015-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 4740
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14735132
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/735132 | Methods and Apparatus for Cell-Free Microfluidic-Assisted Biosynthesis | Jun 8, 2015 | Abandoned |
Array
(
[id] => 10459822
[patent_doc_number] => 20150344837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-03
[patent_title] => 'MINIMAL BACTERIAL GENOME'
[patent_app_type] => utility
[patent_app_number] => 14/733743
[patent_app_country] => US
[patent_app_date] => 2015-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 14823
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14733743
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/733743 | MINIMAL BACTERIAL GENOME | Jun 7, 2015 | Abandoned |
Array
(
[id] => 11514658
[patent_doc_number] => 20170081732
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-23
[patent_title] => 'Method for the Selection of a Long-Term Producing Cell using Histone Acylation as Markers'
[patent_app_type] => utility
[patent_app_number] => 15/311460
[patent_app_country] => US
[patent_app_date] => 2015-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 35614
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15311460
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/311460 | Method for the selection of a long-term producing cell using histone acylation as markers | May 12, 2015 | Issued |
Array
(
[id] => 11356434
[patent_doc_number] => 09533073
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2017-01-03
[patent_title] => 'Microvascular stamp for patterning of functional neovessels'
[patent_app_type] => utility
[patent_app_number] => 14/709726
[patent_app_country] => US
[patent_app_date] => 2015-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 12707
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14709726
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/709726 | Microvascular stamp for patterning of functional neovessels | May 11, 2015 | Issued |
Array
(
[id] => 10347877
[patent_doc_number] => 20150232883
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-20
[patent_title] => 'DELIVERY, USE AND THERAPEUTIC APPLICATIONS OF THE CRISPR-CAS SYSTEMS AND COMPOSITIONS FOR TARGETING DISORDERS AND DISEASES USING PARTICLE DELIVERY COMPONENTS'
[patent_app_type] => utility
[patent_app_number] => 14/705719
[patent_app_country] => US
[patent_app_date] => 2015-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 88
[patent_figures_cnt] => 88
[patent_no_of_words] => 122738
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14705719
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/705719 | DELIVERY, USE AND THERAPEUTIC APPLICATIONS OF THE CRISPR-CAS SYSTEMS AND COMPOSITIONS FOR TARGETING DISORDERS AND DISEASES USING PARTICLE DELIVERY COMPONENTS | May 5, 2015 | Abandoned |
Array
(
[id] => 10347876
[patent_doc_number] => 20150232882
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-20
[patent_title] => 'ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION'
[patent_app_type] => utility
[patent_app_number] => 14/703511
[patent_app_country] => US
[patent_app_date] => 2015-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 44
[patent_no_of_words] => 34730
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14703511
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/703511 | ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION | May 3, 2015 | Pending |
Array
(
[id] => 11457405
[patent_doc_number] => 20170051311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-23
[patent_title] => 'METHODS AND APPARATUS FOR TRANSFORMATION OF NATURALLY COMPETENT CELLS'
[patent_app_type] => utility
[patent_app_number] => 15/308329
[patent_app_country] => US
[patent_app_date] => 2015-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 13577
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15308329
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/308329 | METHODS AND APPARATUS FOR TRANSFORMATION OF NATURALLY COMPETENT CELLS | Apr 30, 2015 | Abandoned |
Array
(
[id] => 10334622
[patent_doc_number] => 20150219624
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-06
[patent_title] => 'METHODS FOR IDENTIFYING ANTI-CANCER COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/693832
[patent_app_country] => US
[patent_app_date] => 2015-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 49047
[patent_no_of_claims] => 94
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14693832
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/693832 | METHODS FOR IDENTIFYING ANTI-CANCER COMPOUNDS | Apr 21, 2015 | Abandoned |
Array
(
[id] => 10407024
[patent_doc_number] => 20150292034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-15
[patent_title] => 'RECEPTOR GENE FOR PEPTIDE CANCER ANTIGEN-SPECIFIC T CELL'
[patent_app_type] => utility
[patent_app_number] => 14/687569
[patent_app_country] => US
[patent_app_date] => 2015-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 11760
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14687569
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/687569 | Receptor gene for peptide cancer antigen-specific T cell | Apr 14, 2015 | Issued |
Array
(
[id] => 10407026
[patent_doc_number] => 20150292035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-15
[patent_title] => 'RECEPTOR GENE FOR PEPTIDE CANCER ANTIGEN-SPECIFIC T CELL'
[patent_app_type] => utility
[patent_app_number] => 14/687628
[patent_app_country] => US
[patent_app_date] => 2015-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 11904
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14687628
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/687628 | RECEPTOR GENE FOR PEPTIDE CANCER ANTIGEN-SPECIFIC T CELL | Apr 14, 2015 | Abandoned |
Array
(
[id] => 14360691
[patent_doc_number] => 10301633
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-28
[patent_title] => Ureohydrolases as dominant selectable markers in yeast
[patent_app_type] => utility
[patent_app_number] => 15/301599
[patent_app_country] => US
[patent_app_date] => 2015-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 12
[patent_no_of_words] => 10979
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15301599
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/301599 | Ureohydrolases as dominant selectable markers in yeast | Apr 12, 2015 | Issued |
Array
(
[id] => 10318869
[patent_doc_number] => 20150203872
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-23
[patent_title] => 'CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS'
[patent_app_type] => utility
[patent_app_number] => 14/681382
[patent_app_country] => US
[patent_app_date] => 2015-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 47
[patent_no_of_words] => 32078
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14681382
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/681382 | CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS | Apr 7, 2015 | Abandoned |
Array
(
[id] => 11895193
[patent_doc_number] => 09765118
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-19
[patent_title] => 'Pharmaceutical composition for cancer prevention and treatment containing peptide originated from C12orf59 protein as an active ingredient'
[patent_app_type] => utility
[patent_app_number] => 14/664048
[patent_app_country] => US
[patent_app_date] => 2015-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 32
[patent_no_of_words] => 14945
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14664048
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/664048 | Pharmaceutical composition for cancer prevention and treatment containing peptide originated from C12orf59 protein as an active ingredient | Mar 19, 2015 | Issued |
Array
(
[id] => 11627643
[patent_doc_number] => 20170137832
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-18
[patent_title] => 'PROCESS FOR PRODUCING CHIMERIC CYCLOOLIGODEPSIPEPTIDES IN FILAMENTOUS FUNGI'
[patent_app_type] => utility
[patent_app_number] => 15/127645
[patent_app_country] => US
[patent_app_date] => 2015-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 6311
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15127645
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/127645 | Process for producing chimeric cyclooligodepsipeptides in filamentous fungi | Mar 19, 2015 | Issued |
Array
(
[id] => 11178956
[patent_doc_number] => 09410946
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-09
[patent_title] => 'Quality control bioassays for nutriceutical and medicinal products'
[patent_app_type] => utility
[patent_app_number] => 14/657537
[patent_app_country] => US
[patent_app_date] => 2015-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11102
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 194
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14657537
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/657537 | Quality control bioassays for nutriceutical and medicinal products | Mar 12, 2015 | Issued |